[Characteristics of the clinical course of poisoning with beryllium compounds].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001607:Berylliosis; D006801:Humans; D011014:Pneumonia / Q000139:chemically induced; D013424:Sulfanilamides / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013424:Sulfanilamides
Osobennosti klinicheskogo techeniia pnevmonii pri intoksikatsii soedineniiami berilliia.